Biotech · Private company

American Regent, Inc.

Track this companyFree. Adds American Regent, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials210 recruiting or active

Pipeline programs22From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline22

CarboplatinPhase 3 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
DacarbazinePhase 3 · Malignant MelanomaClinicalTrials.gov · fetched Nov 12, 2026
Ferric carboxymaltosePhase 3 · Iron Deficiency AnemiaClinicalTrials.gov · fetched Nov 12, 2026
Ferric CarboxymaltosePhase 3 · Heart FailureClinicalTrials.gov · fetched Nov 12, 2026
Ferrous SulfatePhase 3 · AnemiaClinicalTrials.gov · fetched Nov 12, 2026
Ferrous SulfatePhase 3 · Iron Deficiency AnemiaClinicalTrials.gov · fetched Nov 12, 2026
InjectaferPhase 3 · Restless Legs Syndrome (RLS)ClinicalTrials.gov · fetched Nov 12, 2026
InjectaferPhase 3 · Cancer and Chemotherapy Related AnemiaClinicalTrials.gov · fetched Nov 12, 2026
PaclitaxelPhase 3 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Sodium thiosulfatePhase 3 · CalciphylaxisClinicalTrials.gov · fetched Nov 12, 2026
TaxoprexinPhase 3 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
TaxoprexinPhase 3 · Malignant MelanomaClinicalTrials.gov · fetched Nov 12, 2026
VenoferPhase 3 · AnemiaClinicalTrials.gov · fetched Nov 12, 2026
VIT-45Phase 3 · AnemiaClinicalTrials.gov · fetched Nov 12, 2026
Ferric carboxymaltosePhase 2 · Iron Deficiency, AnaemiaClinicalTrials.gov · fetched Nov 12, 2026
Ferric Carboxymaltose (FCM)Phase 2 · Restless LegsClinicalTrials.gov · fetched Nov 12, 2026
Injectafer® (Ferric Carboxymaltose - FCM)Phase 2 · Restless Legs Syndrome (RLS)ClinicalTrials.gov · fetched Nov 12, 2026
TaxoprexinPhase 2 · Cancer of the LiverClinicalTrials.gov · fetched Nov 12, 2026
TaxoprexinPhase 2 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
Luitpold AzacitidinePhase 1 · Myelodysplastic SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Vidaza®Phase 1 · Myelodysplastic SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Venofer (iron sucrose injection)AnemiaClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials21

IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV ApproachesPHASE4 · TERMINATED · started Apr 2, 2025ClinicalTrials.gov NCT07053475 · fetched Nov 12, 2026
Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart FailurePHASE4 · TERMINATED · started Jan 24, 2024ClinicalTrials.gov NCT05816265 · fetched Nov 12, 2026
Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency AnemiaPHASE2 · WITHDRAWN · started Jul 21, 2022ClinicalTrials.gov NCT04968379 · fetched Nov 12, 2026
Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044PHASE3 · COMPLETED · started Nov 19, 2019ClinicalTrials.gov NCT04269707 · fetched Nov 12, 2026
Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDAPHASE3 · COMPLETED · started Jan 31, 2019ClinicalTrials.gov NCT03523117 · fetched Nov 12, 2026
Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency AnemiaPHASE2 · TERMINATED · started Jul 10, 2017ClinicalTrials.gov NCT02826681 · fetched Nov 12, 2026
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-StudyPHASE3 · COMPLETED · started Mar 15, 2017ClinicalTrials.gov NCT03037931 · fetched Nov 12, 2026
Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®PHASE3 · COMPLETED · started May 23, 2015ClinicalTrials.gov NCT02453334 · fetched Nov 12, 2026
Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic ArteriolopathyPHASE3 · WITHDRAWN · started Jan 30, 2015ClinicalTrials.gov NCT02527213 · fetched Nov 12, 2026
Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLSPHASE3 · COMPLETED · started Jan 1, 2015ClinicalTrials.gov NCT02397057 · fetched Nov 12, 2026
Registry to Evaluate Maintenance Treatment With Venofer in Pediatric Patients With Chronic Kidney DiseaseCOMPLETED · started Sep 1, 2014ClinicalTrials.gov NCT02492672 · fetched Nov 12, 2026
An Efficacy and Safety Trial of Intranasal Ketorolac in Emergency Department Patients for the Treatment of Acute PainNA · COMPLETED · started Nov 1, 2011ClinicalTrials.gov NCT01471639 · fetched Nov 12, 2026
Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs VidazaPHASE1 · COMPLETED · started Nov 22, 2010ClinicalTrials.gov NCT01290302 · fetched Nov 12, 2026
Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary TractPHASE2 · TERMINATED · started Jan 1, 2007ClinicalTrials.gov NCT00422877 · fetched Nov 12, 2026
Intravenous Iron Metabolism in Restless Legs SyndromePHASE2 · COMPLETED · started Nov 1, 2006ClinicalTrials.gov NCT00685815 · fetched Nov 12, 2026
Taxoprexin Plus Carboplatin Treatment for Advanced Lung CancerPHASE3 · COMPLETED · started Nov 1, 2005ClinicalTrials.gov NCT00243867 · fetched Nov 12, 2026
Taxoprexin® Treatment for Advanced Eye MelanomaPHASE2 · COMPLETED · started Oct 1, 2005ClinicalTrials.gov NCT00244816 · fetched Nov 12, 2026
Safety and Efficacy of Iron Sucrose in ChildrenPHASE4 · COMPLETED · started Jul 1, 2005ClinicalTrials.gov NCT00239642 · fetched Nov 12, 2026
Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency AnemiaPHASE3 · COMPLETED · started Jul 1, 2005ClinicalTrials.gov NCT00740246 · fetched Nov 12, 2026
Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With AnemiaPHASE3 · COMPLETED · started Aug 1, 2003ClinicalTrials.gov NCT00236977 · fetched Nov 12, 2026
Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant MelanomaPHASE3 · TERMINATED · started Dec 6, 2002ClinicalTrials.gov NCT00087776 · fetched Nov 12, 2026